MDS clinical diagnostic criteria for Parkinson's disease

Berg, 2014, Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease, Mov Disord, 29, 454, 10.1002/mds.25844

Berg, 2015, MDS Research Criteria for Prodromal Parkinson's Disease, Mov Disord, 10.1002/mds.26431

Gibb, 1988, The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease, J Neurol Neurosurg Psychiatry, 51, 745, 10.1136/jnnp.51.6.745

Calne, 1992, Criteria for diagnosing Parkinson's disease, Ann Neurol, 32, S125, 10.1002/ana.410320721

Gelb, 1999, Diagnostic criteria for Parkinson disease, Arch Neurol, 56, 33, 10.1001/archneur.56.1.33

Litvan, 2003, Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders, Mov Disord, 18, 467, 10.1002/mds.10459

Berg, 2013, Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities, Lancet Neurol, 12, 514, 10.1016/S1474-4422(13)70047-4

Rajput, 1991, Accuracy of clinical diagnosis in parkinsonism: a prospective study, Can J Neurol Sci, 18, 275, 10.1017/S0317167100031814

Hughes, 2001, Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease, Neurology, 57, 1497, 10.1212/WNL.57.8.1497

Hughes, 1992, Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases, J Neurol Neurosurg Psychiatry, 55, 181, 10.1136/jnnp.55.3.181

Tolosa, 2006, The diagnosis of Parkinson's disease, Lancet Neurol, 5, 75, 10.1016/S1474-4422(05)70285-4

Litvan, 1998, Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study, Arch Neurol, 55, 969, 10.1001/archneur.55.7.969

Adler, 2014, Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study, Neurology, 83, 406, 10.1212/WNL.0000000000000641

Hughes, 2002, The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service, Brain, 125, 861, 10.1093/brain/awf080

Kollensperger, 2008, Red flags for multiple system atrophy, Mov Disord, 23, 1093, 10.1002/mds.21992

McKeith, 2005, Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium, Neurology, 65, 1863, 10.1212/01.wnl.0000187889.17253.b1

Shah, 2008, Olfactory tests in the diagnosis of essential tremor, Parkinsonism Relat Disord, 14, 563, 10.1016/j.parkreldis.2007.12.006

Wenning, 1995, Olfactory function in atypical parkinsonian syndromes, Acta Neurol Scand, 91, 247, 10.1111/j.1600-0404.1995.tb06998.x

Muller, 2002, Olfactory function in Parkinsonian syndromes, J Clin Neurosci, 9, 521, 10.1054/jocn.2001.1071

Goldstein, 2008, Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy, Parkinsonism Relat Disord, 14, 600, 10.1016/j.parkreldis.2008.01.010

Katzenschlager, 2004, Olfactory function distinguishes vascular parkinsonism from Parkinson's disease, J Neurol Neurosurg Psychiatry, 75, 1749, 10.1136/jnnp.2003.035287

Kikuchi, 2011, Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test, Parkinsonism Relat Disord, 17, 698, 10.1016/j.parkreldis.2011.07.011

Suzuki, 2011, The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy, BMC Neurol, 11, 157, 10.1186/1471-2377-11-157

Busse, 2012, Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease, J Neurol Neurosurg Psychiatry, 83, 441, 10.1136/jnnp-2011-301719

Rahayel, 2012, The effect of Alzheimer's disease and Parkinson's disease on olfaction: a meta-analysis, Behav Brain Res, 231, 60, 10.1016/j.bbr.2012.02.047

Orimo, 2012, 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis, Parkinsonism Relat Disord, 18, 494, 10.1016/j.parkreldis.2012.01.009

Yoshita, 1997, [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy], Rinsho Shinkeigaku, 37, 476

Shin, 2006, Clinical implications of cardiac-MIBG SPECT in the differentiation of Parkinsonian syndromes, J Clin Neurol, 2, 51, 10.3988/jcn.2006.2.1.51

Kashihara, 2006, Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies, J Nucl Med, 47, 1099

Goetz, 2008, Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results, Mov Disord, 23, 2129, 10.1002/mds.22340

Rascovsky, 2011, Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia, Brain, 134, 2456, 10.1093/brain/awr179

Gilman, 2008, Second consensus statement on the diagnosis of multiple system atrophy, Neurology, 71, 670, 10.1212/01.wnl.0000324625.00404.15